In cancer, DHCR7 inhibition elevates 7‐DHC, suppressing ferroptosis but paradoxically promoting metastasis, while targeting upstream enzymes (e.g., EBP) to deplete 7‐DHC induces ferroptosis and inhibits tumor growth [8, 9]. Here, DHCR7 is linked to neoplasm.